deltatrials

Generalized anxiety disorder Trials in Houston, United States

Conditions / Generalized anxiety disorder / Houston, United States

Generalized anxiety disorder has been the subject of sustained clinical investigation across multiple research sites.

24 total trials for this combination

Showing top 10 of 24 trials

Trials

NCT ID Title Status Phase
NCT00735267 A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) TERMINATED PHASE3
NCT03720795 Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety COMPLETED NA
NCT00329446 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder COMPLETED PHASE3
NCT00616655 Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects COMPLETED PHASE2
NCT00235508 Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder COMPLETED PHASE4
NCT00731120 Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder COMPLETED PHASE3
NCT06046170 Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA) COMPLETED NA
NCT00730691 Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder COMPLETED PHASE3
NCT06537128 Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety RECRUITING NA
NCT04111874 Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD COMPLETED NA

Related Pages